Bcl-2 and LMP1 expression in nasopharyngeal carcinomas

Area of Science:

• Oncology
• Virology
• Immunology

Background:

• Epstein-Barr Virus (EBV) infection is linked to nasopharyngeal carcinoma (NPC).
• In vitro studies show EBV latent membrane protein 1 (LMP1) upregulates B-cell leukemia/lymphoma-2 (bcl-2) in B-cells and epithelial cells.
• The correlation between LMP1 and bcl-2 in NPC remains unclear.

Purpose of the Study:

• To investigate the relationship between LMP1 and bcl-2 expression in undifferentiated NPC.
• To determine if LMP1 and bcl-2 can serve as biomarkers for treatment response or patient survival in NPC.
• To explore the association between LMP1, bcl-2, and clinical prognostic factors.

Main Methods:

• Retrospective analysis of 35 undifferentiated NPC cases.
• Immunohistochemical assessment of LMP1 and bcl-2 protein expression.
• Statistical analysis to correlate marker expression with survival and clinical variables.

Main Results:

• bcl-2 was expressed in 74.3% and LMP1 in 28.6% of NPC cases.
• A significant correlation was found between bcl-2 and LMP1 expression (P =.003).
• Cervical lymph node metastasis (P =.04) and cranial nerve involvement (P =.03) were significant predictors of survival.
• bcl-2 and LMP1 expression were strongly correlated with cervical lymph node metastasis.

Conclusions:

• bcl-2 and LMP1 expression are not significant direct indicators of patient survival in NPC.
• While bcl-2 expression may be independent of LMP1, their combined presence is linked to cervical lymph node metastasis.
• Cervical lymph node metastasis is a potent predictor of survival in NPC patients.